ENDRA Life Sciences (NDRA) Earnings Analysis

ENDRA Life Sciences (NDRA) next reports earnings on 2026-08-13, consensus EPS -0.84 USD. Last quarter (2026-05-18) it beat with EPS -1.09 USD vs -1.23 USD est (+11.4%). It has beaten estimates in 5/8 recent quarters (63%). Trailing P/E -0.69.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does NDRA next report earnings?

Next earnings date2026-08-13
Consensus EPS estimate-0.84 USD
Revenue estimate0.00B

NDRA earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-18-1.09 USD-1.23 USD+11.4%Beat
2026-03-31-3.26 USD-1.23 USD-165%Miss
2025-11-14-1.75 USD-1.95 USD+10.3%Beat
2025-08-14-1.71 USD-2.27 USD+24.7%Beat
2025-05-15-2.59 USD-3.91 USD+33.8%Beat
2025-03-31-9.4 USD-4.1 USD-129.3%Miss
2024-11-15-5.85 USD-62.3 USD+90.6%Beat
2024-08-22-139.86 USD-122.5 USD-14.2%Miss

Beat rate: 5/8 (63%) over reported quarters with consensus data.

NDRA valuation and analyst view

Trailing P/E-0.69
Trailing EPS-6.08753 USD
Price / book3.77
Dividend yield0.00%
Market cap0.00B
Analyst consensusBuy (4 buy / 0 hold / 0 sell)

Related research pages

Frequently asked questions

When is ENDRA Life Sciences (NDRA)'s next earnings date?

ENDRA Life Sciences is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.84 USD and revenue estimate of 0.00B.

Did NDRA beat earnings last quarter?

In its 2026-05-18 report, NDRA posted EPS of -1.09 USD versus a -1.23 USD estimate — a beat of 11.4%.

What is NDRA's earnings track record?

Over the last 8 reported quarters with consensus data, NDRA beat estimates 5 times (63%).

What is NDRA's current P/E ratio and EPS?

NDRA trades at a trailing P/E of -0.69 on trailing EPS of -6.087527697055484 USD.

What do analysts rate NDRA?

Analyst consensus is "Buy" across 4 ratings (0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell).